MICHAEL THIEBLEMONT: Open Payments
NPI 1003876947 · NEWPORT, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,310 in 61 payments from 23 companies in 2025. Trend: 2023 $686 · 2024 $952 · 2025 $1,310
Food & beverage: $1,310
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $280 |
| Novo Nordisk Inc | 12 | $187 |
| PFIZER INC. | 8 | $160 |
| Axsome Therapeutics, Inc. | 3 | $120 |
| AstraZeneca Pharmaceuticals LP | 4 | $72 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $51 |
| CeQur Corporation | 1 | $48 |
| Reflow Medical Inc | 1 | $43 |
| Merck Sharp & Dohme LLC | 2 | $34 |
| Kowa Pharmaceuticals America, Inc. | 2 | $34 |
Products named: VRAYLAR, Auvelity, NURTEC ODT, Wegovy, Rybelsus, ELIQUIS, AIRSUPRA, JARDIANCE.
Industry payments across PA — which companies pay providers there.
